FDA approves New Drug Application for PENNSA 2%


Posted in: Medical Condition News | Pharmaceutical News

Tags: Abdominal Pain, Anti-Inflammatory, Aspirin, Asthma, Blood, Blood Pressure, Cardiovascular Disease, Coronary Artery Bypass Graft, Dermatitis, Diarrhea, Drugs, Dyspepsia, Erythema, Exercise, Flatulence, Healthcare, Heart Failure, Hypersensitivity, Hypertension, Medical Imaging, Nausea, New Drug Application, Osteoarthritis, Pain, Placebo, Pruritus, Stroke, technology, Urinary Tract Infection, Urticaria